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Abstract	
	
	
Estrogens,	in	addition	to	testosterone,	are	much	more	physiologically	relevant	to	normal	sperm	
production	in	the	testis	and	overall	male	fertility	than	previously	thought.	Current	use	herbicides,	
such	as	atrazine,	are	known	endocrine	disruptors	and	have	been	suggested	to	disrupt	male	
reproductive	health.	The	purpose	of	this	study	was	to	investigate	the	effect	of	chronic	atrazine	
exposure	on	male	reproductive	function	in	Sprague	Dawley	rats.		Three	groups	of	rats	were	treated	
until	7	months	of	age.	The	first	group	was	the	control	vehicle	and	given	only	water.	The	second	
group	was	given	a	low	dose	of	atrazine	(0.1	mg/kg)	and	the	third	group	was	given	a	high	dose	of	
atrazine	(10	mg/kg)	via	oral	gavage	to	mimic	the	most	common	exposure	to	atrazine	in	humans.		At	
7	months	of	age,	animals	were	euthanized	and	reproductive	tissues	were	collected	for	analysis.	
Concentrations	of	testosterone	were	not	significantly	different	between	groups,	but	levels	of	serum	
FSH	and	estradiol	were	significantly	increased	in	the	high	dose	group	relative	to	the	control.	
Sperm/gram	of	the	testis	was	significantly	lower	in	the	low	dose	group	and	daily	sperm	production	
was	significantly	lower	in	the	high	dose	group.	Collectively,	these	results	support	the	hypothesis	
that	sperm	production	and	overall	male	reproductive	health	is	significantly	disrupted	by	chronic	
exposure	to	atrazine,	and	the	relationship	between	estradiol	and	male	fertility	is	sensitive	to	
environmental	contaminants.		
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Chapter	1.	Introduction		
	 A	marked	decline	of	semen	quality	(semen	volume,	sperm	motility,	sperm	count	and	
normal	morphology)	in	normal	men	has	been	reported	over	the	past	few	decades.	Associations	
between	current-use	pesticides	and	reduced	semen	quality	suggest	that	agricultural	chemicals	
may	contribute	to	the	reduced	semen	quality	seen	in	fertile	men	from	agricultural	regions	of	
the	United	States	(Swan,	2006).	Results	from	a	study	comparing	semen	quality	of	men	from	
different	regions	of	the	United	States	indicated	that	changes	in	semen	quality	were	associated	
with	exposure	to	several	common	pesticides	currently	being	used	(Swan	et	al.,	2003)	including	
the	active	ingredient	atrazine.		
	 	It	has	been	reported	that	in	females,	leuteninzing	hormone	(LH)	release	was	suppressed	
(McMullin	et	al.,	2004)	while	in	males	follicle	stimulating	hormone	(FSH)	was	increased	
(Kniewald	et	al.,	2000)	after	atrazine	exposure.	Leydig	cells,	responsible	for	synthesizing	
testosterone,	were	of	irregular	shape	with	unequal	form.	In	Sertoli	cell	cytoplasm,	the	cells	
responsible	for	the	maintenance	of	developing	germ	cells,	atrazine	provoked	degenerative	
changes	(Kniewald	et	al.,	2000).	This	result	in	males	has	been	hypothesized	to	be	a	possible	
mechanism	by	which	the	male	reproductive	tract	and	overall	fertility	have	been	affected	by	
atrazine	(Babić-Gojmerac	et	al.,	1989).	The	mechanisms	by	which	atrazine	alters	the	male	
reproductive	tract	are	poorly	understood	and	have	not	been	thoroughly	analyzed,	thus	it	is	
important	to	bridge	the	gap	between	infertility	and	atrazine	exposure	beyond	serum	hormone	
analysis.		
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Purpose	
	 The	purpose	of	this	study	was	to	determine	the	effects	of	chronic	atrazine	exposure	on	
male	reproductive	function.	
Scope	
	 Male	reproductive	function	includes	spermatogenesis,	hormone	production,	and	
maintenance	of	the	testis	and	epididymis.	Any	alterations	in	these	aspects	of	male	reproductive	
endocrinology	and	sexual	development	can	cause	a	significant	drop	in	male	fertility	and	overall	
male	reproductive	health.	We	will	determine	the	extent	that	male	reproductive	function	is	
altered	in	response	to	chronic	atrazine	exposure	by	focusing	on	sperm	production	and	
homeostasis	of	testosterone,	estradiol,	FSH,	LH,	and	the	enzyme	CYP19,	commonly	known	as	
aromatase.	
Assumptions	
1. Estradiol,	within	specific	physiological	ranges,	is	essential	for	maintaining	proper	male	
reproductive	function.	
2. Atrazine	contributes	to	the	adverse	trends	observed	in	male	fertility	and	is	currently	
attributed	to	disrupting	endocrine	function	in	developing	and	adult	males.	
Hypothesis	
	 We	hypothesize	that	atrazine	disrupts	proper	endocrine	function	in	developing	and	
adult	male	rats	and	has	negative	effects	on	sperm	production	and	fertility.	
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Significance	
	 Because	male	sperm	concentration	has	been	reported	to	decline	52%	and	overall	sperm	
count	has	dropped	59%	over	the	past	40	years	in	North	America,	a	better	understanding	of	the	
effects	of	commonly	known	endocrine	disruptors	is	essential.	These	effects	on	male	fertility	are	
relevant	now	more	than	ever	as	the	United	States	population	is	waiting	longer,	on	average,	in	
attempting	to	conceive.	Endocrine	disrupting	chemicals	such	as	atrazine	are	commonly	used	in	
the	United	States	and	are	highly	concentrated	in	agricultural	regions.	More	concrete	knowledge	
on	the	developmental	and	life-long	effects	of	chronic	exposure	to	atrazine	will	prove	useful	in	
the	battle	for	fertility.	This	report	is,	to	our	knowledge,	the	first	to	examine	the	direct	effects	of	
atrazine	on	hormone	levels,	sperm	production,	and	expression	of	aromatase	in	the	male	
mammalian	testis	in	a	single	study.	 	
	 	 		
	 10	
Chapter	2.	Review	of	Literature	
Current	State	of	Male	Fertility	 	
	 Male	reproductive	health	has	deteriorated	in	many	countries	(Toppari	et	al.,	1996)	and	
the	latest	meta-regression	analysis	from	Levine	et	al.	reports	a	significant	decline	in	sperm	
counts	between	1973	and	2011,	driven	by	a	50-60%	decline	among	men	unselected	by	fertility	
from	North	America,	Europe,	Australia,	and	New	Zeeland	(Levine	et	al.,	2017).	Carlsen	et	al.	
(1992)	published	a	provocative	study	which	suggested	that	human	semen	quality	had	declined	
by	roughly	50%	from	1930	to	1990	(Fisher,	2004;	Carlsen	et	al.,	1992).	Haimov-Kochman	et	al.	
conducted	a	15-year	longitudinal	study	from	1995	to	2009	by	obtaining	weekly	sperm	samples	
taken	from	58	sperm	donors	in	Israel	and	found	that	average	sperm	concentrations	dropped	
from	106	x	106/ml	with	79%	motility	to	68	x	106/ml	with	66%	motility	(Haimov-Kochman	et	al.,	
2012).	A	decline	in	semen	quality	could	constitute	a	decrease	in	semen	volume,	sperm	motility,	
sperm	count,	and/or	adverse	deviations	from	normal	sperm	morphology.	Many	subsequent	
studies	criticized	or	re-analyzed	the	original	meta-analysis	of	Carlsen	et	al.,	but	the	trends	and	
conclusions	have	been	reaffirmed	(Fisher,	2004;	Swan	et	al.,	2000).	Initial	results	from	
prospective	European	studies	have	shown	regional	differences	in	semen	quality	between	
Denmark,	France,	Scotland,	and	Finland;	the	median	sperm	concentrations	were	61	x	106/ml,	
74	x	106/ml,	77	x	106/ml,	and	82	x	106/ml,	respectively	(Jørgensen	et	al.,	2001).	Jørgensen	et	al.	
published	a	cross-sectional	study	in	2012	of	4,867	Danish	men	in	Copenhagen,	Denmark,	that	
revealed	only	23%	of	that	sample	population	had	optimal	sperm	concentration	and	sperm	
morphology	(Jørgensen	et	al.,	2012).	Recent	studies	published	in	the	United	States,	which	used	
identical	methodologies	to	the	European-based	studies,	have	also	reported	geographical	
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differences	in	sperm	quality;	the	mean	sperm	count	in	Columbia,	Missouri	(58.7	x	106/ml)	
compared	to	New	York,	New	York	(102.9	x	106/ml)	is	striking	(Fisher,	2004;	Swan	et	al.,	2003).	
Sperm	concentrations	below	40	x	106/ml	are	generally	considered	subfertile/infertile.		
	 Sperm	count	is	of	considerable	public	health	importance	for	several	reasons.	First,	
sperm	count	is	closely	linked	to	male	fecundity	and	is	a	crucial	component	of	semen	analysis,	
the	first	step	to	identify	male	factor	infertility	(World	Health	Organization,	2010;	Wang	and	
Swerdloff,	2014).	Second,	the	economic	and	societal	burden	of	male	infertility	is	high	and	
increasing	(Winters	and	Walsh,	2014;	Hauser	et	al.,	2015;	Skakkebaek	et	al.,	2015).	Third,	
reduced	sperm	count	predicts	increased	all-cause	mortality	and	morbidity	(Jensen	et	al.,	2009;	
Eisenberg	et	al.,	2014).	Fourth,	reduced	sperm	count	is	associated	with	cryptorchidism,	
hypospadias	and	testicular	cancer,	suggesting	a	shared	prenatal	etiology	(Skakkebaek	et	al.,	
2015).	Fifth,	and	most	relevant	to	this	study,	sperm	count	and	other	semen	parameters	have	
been	plausibly	associated	with	multiple	environmental	influences,	including	endocrine	
disrupting	chemicals	(Bloom	et	al.,	2015;	Gore	et	al.,	2015),	pesticides	(Chiu	et	al.,	2016),	and	
lifestyle	factors	(Afeiche	et	al.,	2013;	Jensen	et	al.,	2013).	Therefore,	sperm	count	may	
sensitively	reflect	the	impacts	of	the	modern	environment	on	male	reproductive	health	and	the	
male	gonad	throughout	the	course	of	life	(Nordkap	et	al.,	2012).	
	 	
Testicular	Anatomy	and	Function	
	 The	male	gonad,	the	testis	and	reproductive	tract,	serves	the	dual	function	of	sperm	
production	and	hormone	synthesis.	The	testis	and	reproductive	tract	are	composed	of	(in	
order):	seminiferous	tubules,	rete	testis,	efferent	ducts,	and	the	epididymis	(Figure	1).	The	two	
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principal	functions	of	the	testis,	sperm	production	and	hormone	synthesis,	are	carried	out	in	
morphologically	distinct	compartments.		
Figure	1.	Anatomy	of	the	Male	Testis	
Berne,	Robert	M.,,	Koeppen,	Bruce	M.Stanton,	Bruce,	A.,	eds.	Berne	&	Levy	Physiology.	Philadelphia	:	
Mosby/Elsevier,	2008.	Print.	
	
The	seminiferous	tubules,	in	the	first	section	of	the	male	gonad	comprising	the	bulk	of	
testicular	mass,	house	Sertoli	cells	and	in	the	interstitial	space	are	the	Leydig	cells.	Sertoli	cells	
are	responsible	for	the	maintenance	and	coordination	of	developing	germ	cells	(immature	
sperm	cells),	in	a	process	called	spermatogenesis,	and	are	located	inside	of	the	lumen	of	
seminiferous	tubules.	Spermatogenesis	can	be	divided	into	three	discrete	phases:	1.	Mitotic	
divisions,	which	maintain	a	stem	cell	population	of	spermatogonia	and	provide	the	cells	
destined	to	become	mature	sperm;	2.	Meiotic	divisions,	which	reduce	the	chromosome	number	
and	produce	a	cluster	of	haploid	spermatids;	3.	Transformation	of	spermatids	into	mature	
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spermatozoa,	a	process	involving	the	loss	of	the	cytoplasm	on	their	heads	and	the	development	
of	flagella.	Sertoli	cells	also	secrete	the	watery	fluid	that	transports	spermatozoa	through	the	
seminiferous	tubules	and	into	the	epididymis,	where	99%	of	the	fluid	is	reabsorbed.		
	 The	primary	role	of	Leydig	cells	is	synthesizing	and	secreting	the	steroid	hormone	
testosterone	when	stimulated	by	an	upstream	hormone.	Although	extensive	at	birth,	Leydig	cell	
function	virtually	disappears	after	the	first	six	months	of	postnatal	life	in	humans,	only	to	
reappear	more	than	a	decade	later	with	the	onset	of	puberty.	In	the	adult,	Leydig	cells	comprise	
10-20%	of	testicular	mass	(Goodman,	2009).	Testosterone	released	from	Leydig	cells	can	either	
diffuse	into	nearby	capillaries	for	general	circulation,	or	may	diffuse	into	seminiferous	tubules	
where	it	performs	its	essential	role	in	spermatogenesis,	which	will	be	addressed	later.	
	 Developing	sperm	travel	through	the	seminiferous	tubules	to	the	rete	testis,	through	
the	efferent	ducts,	and	then	to	the	epididymis	where	they	mature	and	gain	motility.	The	
primary	function	of	the	efferent	ducts	is	fluid	reabsorption	in	order	to	concentrate	the	sperm.	
Efferent	duct-fluid	reabsorption	is	under	hormonal	control	of	another	steroid	hormone,	17β-
estradiol	or	simply	estradiol,	the	primary	form	of	estrogen	in	humans.	Without	proper	estradiol	
signaling,	fluid	reabsorption	will	not	occur	and	spermatogenesis	will	be	disrupted	(Hess,	2000).	
	 Transit	of	spermatids	through	the	epididymis	is	crucial	for	sperm	maturation.	The	
epididymis	is	divided	into	three	major	regions:	caput,	corpus,	and	cauda.	The	caput	is	the	head	
of	the	epididymis,	which	receives	immature	sperm	from	the	efferent	ducts	and	begins	the	
process	of	sperm	maturation.	The	corpus	is	the	body	of	the	epididymis,	and	this	is	where	sperm	
gain	motility.	The	final	section	is	the	cauda,	or	the	tail,	where	sperm	are	stored	until	
ejaculation.	Mature	sperm	then	travel	through	the	vas	deferens	from	the	cauda	and	are	
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expelled	through	the	urethral	orifice.	The	importance	of	testosterone	and	estradiol	and	their	
roles	in	the	male	reproductive	tract	and	overall	male	health	cannot	be	understated.	They	are	
the	key	messengers	of	reproductive	and	development	information	and	are	crucial	for	
facilitating	proper	sperm	production	and	proper	male	reproductive	function.		
	 In	order	for	hormones	to	regulate	physiologic	processes,	their	secretion	and	subsequent	
actions	must	be	turned	on	and	off	at	precisely	the	right	times.	The	organism	must	have	some	
way	of	knowing	when	there	is	a	need	for	a	hormone	to	be	secreted,	how	much	is	needed,	and	
when	that	need	has	passed	(Goodman,	2009).	Secretion	of	most	hormones	is	regulated	by	
negative	feedback.	This	means	that	some	consequence	of	hormone	secretion	acts	directly	or	
indirectly	on	the	endocrine	cell	secreting	it	in	a	negative	way	in	order	to	inhibit	further	
secretion.	There	is	also	secretion	regulation	by	means	of	positive	feedback.	Positive	feedback	
means	some	consequence	of	hormonal	secretion	acts	on	the	endocrine	cell	secreting	it	to	
provide	an	augmented	response	resulting	in	further	secretion	of	that	hormone.	Positive	
feedback	systems	are	more	rare	and	usually	end	in	some	sort	of	large	and	observable	event,	as	
is	the	case	with	oxytocin	secretion	and	causing	contraction	of	uterine	muscle	during	childbirth.		
	 The	male	reproductive	tract,	including	the	process	of	spermatogenesis,	is	under	
hormonal	control	of	one	branch	of	the	endocrine	system	called	the	hypothalamic-pituitary-
gonadal	axis	(HPG-Axis).	The	male	HPG-Axis	is	a	relatively	simple	negative	feedback	loop,	in	
which	it’s	designated	effects	(production	and	secretion	of	testosterone	and	inhibin)	temporarily	
shut	down	the	axis	until	hormone	levels	are	reduced	(Figure2).		
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Figure	2.	Hypothalamic-Pituitary-Gonadal	Axis.	
The	HPG-Axis	is	the	endocrine	system	that	regulates	male	reproductive	endocrinology. Campbell,	Simon,	
Reese	and	Dicky	Biology,	Pearson/Benjamin	Cummings		2010,	Marieb;	Human	Anatomy	&	Physiology	
5th	edition,	Benjamin	Cummings,	San	Francisco	2001.	
	
	 This	HPG-Axis	begins	when	Gonadotropin	Releasing	Hormone	(GnRH)	is	secreted	from	
the	hypothalamus	in	response	to	low	levels	of	testosterone	in	the	blood.	GnRH	then	travels	to	
the	pituitary	gland	via	the	blood	and	stimulates	the	anterior	pituitary	to	secrete	LH	and	FSH,	
which	both	subsequently	travel	to	the	testis	via	the	blood.	Inhibin	is	a	protein	hormone	
synthesized	in	Sertoli	cells	and	stimulated	by	testosterone.	It	is	designed	to	inhibit	the	further	
synthesis	and	secretion	of	FSH	from	the	anterior	pituitary	(Skinner	et	al.,	1989).	Sertoli	cells	
within	the	seminiferous	tubules	respond	to	FSH.	Sertoli	cells	are	the	only	cells	known	to	express	
FSH	receptors	in	human	males	and	therefore	the	only	targets	of	FSH.	FSH	stimulates	Sertoli	cells	
to	proliferate	and	differentiate	as	well	as	produce	growth	and	survival	factors	that	prevent	
germ	cell	apoptosis.			
	 Leydig	cells	within	the	interstitial	space	respond	to	LH	and	their	principal	role	is	
stimulating	the	synthesis	of	testosterone.	As	previously	stated,	testosterone	synthesized	in	
Leydig	cells	is	vital	in	supporting	germ	cell	development	within	the	seminiferous	tubules.	It	also	
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has	a	number	of	physiological	effects	important	for	normal	male	development	including:	
development	of	primary	and	secondary	sex	characteristics	(testis	formation/external	genitals	
and	pubic/facial	hair,	respectively),	increases	in	bone	and	muscle	mass,	as	well	as	a	strong	
influence	on	masculine	behavior.	Sertoli	cells	lack	receptors	for	LH,	but	are	rich	with	androgen	
(testosterone)	receptors,	indicating	the	actions	of	LH	on	Sertoli	cell	function	are	indirect,	and	
are	mediated	by	testosterone,	which	reaches	them	in	high	concentrations	via	diffusion	through	
the	blood-testis	barrier	(Goodman,	2009).	Developing	human	sperm	cells	lack	androgen	
receptors,	but	do	express	receptors	for	estradiol,	indicating	that	support	of	sperm	cell	
development	by	testosterone	is	also	exerted	indirectly	by	that	of	Sertoli	cells,	yet	directly	by	
estradiol	synthesis	in	the	testis	(Goodman,	2009).	Interestingly,	Leydig	cells	are	also	the	primary	
source	of	testicular	estradiol	via	the	enzyme	aromatase	(CYP19),	which	converts	testosterone	
into	estradiol	(Figure	3).	Sertoli	cells	and	Leydig	cells,	as	well	as	seminiferous	tubules,	efferent	
ducts,	and	the	epididymis	express	the	aromatase	enzyme,	suggesting	that	estradiol	may	have	
other	important	responsibilities	in	normal	sperm	formation	and	maturation	(Carreau	and	Hess,	
2010).	
	
	 Figure	3.	Aromatase	Function.	
The	function	of	the	enzyme	aromatase	is	to	convert,	or	aromatize,	the	A-ring	of	the	steroid	hormone	
testosterone,	into	estradiol.	Leder	BZ,	Rohrer	JL,	Rubin	SD,	Gallo	J,	Longcope	C	(March	2004).	“Effects	of	
aromatase	inhibition	in	elderly	men	with	low	or	borderline-low	serum	testosterone	levels”.	J.	Clin.	
Endocrinol.	Metab.	89	(3):	1174–80.	
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	 It	has	been	well	documented	that	testosterone	is	necessary	for	proper	spermatogenesis	
and	male	development	(Dohle	et	al.,	2003;	Kliesch,	2010;	Wang	et	al.,	2009;	Collins	et	al.,	2003).	
In	recent	years,	the	role	of	estradiol	has	been	established	as	an	integral	component	for	
spermatogenesis	as	well	(Cooke	et	al.,	2017).	Previous	studies	have	demonstrated	that	
physiology	of	the	male	testis	and	epididymis	are	in	part	under	the	control	of	a	balance	of	
androgens	(testosterone)	and	estrogens	(estradiol),	with	the	enzyme	aromatase	(CYP19)	
converting	testosterone	into	estradiol	(Carreau	and	Hess,	2010).		Estrogen	receptors	α	(ERα)	
and	β	(ERβ)	are	expressed	within	the	testis	and	epididymis	of	multiple	species,	including	
humans	and	rats	(Carreau	and	Hess,	2010),	suggesting	that	the	male	reproductive	tract	is	both	
a	source	and	target	for	estrogen	regulation	(Clarke	and	Pearl,	2014).	ERβ	is	present	in	the	nuclei	
and	cytoplasm	of	all	epididymal	regions	in	rats	and	other	mammalian	species,	including	humans	
(Zaya	et	al.,	2012).	ERα	is	present	in	epididymal	epithelial	cell	nuclei	and	cytoplasm,	and	on	the	
sperm	in	rats.	Recently,	a	third	form	of	the	estrogen	receptor,	G	protein-coupled	estrogen	
receptor	(GPER),	has	been	identified	(Martínez-Traverso	and	Pearl,	2015).	These	types	of	
receptors	are	expressed	on	the	cell	surface	within	the	membrane	of	cells,	unlike	ERα	and	ERβ,	
which	are	intracellular.	
	 There	are	a	number	of	important	roles	estradiol	performs	within	the	male	testis	and	one	
such	role	is	the	regulation	of	fluid	reabsorption	within	the	efferent	ducts,	as	stated	previously.	
The	loss	of	estrogen	receptor	function	in	males	interferes	with	fluid	reabsorption	of	the	
efferent	ducts,	a	function	essential	for	fertility	(Hess,	2000).	When	efferent	ducts	fail	to	
properly	reabsorb	fluid,	a	backpressure	develops	resulting	in	testicular	atrophy	and	infertility	
(Hess	et	al.,	1997).	Also,	in	rodent	models	lacking	complete	estrogen	production	such	as	
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aromatase	knockout	(ArKO)	mice	(Robertson	et	al.	1999),	or	when	estrogen	production	is	
reduced	by	aromatase	inhibitors	(Kondarewicz	et	al.,	2012),	rats	experience	progressive	
infertility	until	spermatogenesis	becomes	severely	impaired	(Kondarewicz	et	al.,	2012).	A	
regional	expression	pattern	of	a	G	protein-coupled	estrogen	receptor	(GPER)	in	the	epididymis	
of	multiple	strains	of	rats	has	been	demonstrated	(Martínez-Traverso	and	Pearl,	2015)	and	the	
percentage	of	mature	sperm	greatly	increases	in	the	corpus	where	GPER	expression	is	highest,	
which	suggests	GPER	signaling	may	have	a	role	in	sperm	maturation	(Albanito	et	al.,	2015).	
	 Furthermore,	estradiol	appears	to	regulate	apoptosis	of	rat	Sertoli	Cells	(Royer	et	al.,	
2012)	as	well	as	the	inhibition	of	apoptosis	in	human	germ	cells	in	vitro	(Pentikäinen	et	al.,	
2000).	Germ	cell	apoptosis	appears	to	occur	at	a	higher	rate	in	the	aged	testis	(Barnes	et	al.,	
1998),	which	is	one	mechanism	daily	sperm	production	could	be	reduced.	Thus,	it	is	possible	
that	reduced	estradiol	within	the	testis	during	aging	leads	to	increased	germ	cell	apoptosis	and	
lower	overall	daily	sperm	production	(Clarke	and	Pearl,	2014).				
	 The	work	previously	described	suggests	too	little	estradiol	adversely	affects	
spermatogenesis	and	overall	male	fertility,	and	males	lacking	estradiol	signaling	in	the	
reproductive	tissues	are	infertile.	However,	it	is	equally	important	that	serum	and	testicular	
estradiol	levels	and	actions	do	not	increase	above	the	normal	functional	range	in	males.	
Estradiol	is	clearly	involved	in	the	negative	feedback	effects	of	testosterone	on	the	brain	to	
control	pituitary	gonadotropin	secretion,	and	hence	an	absence	of	(or	inappropriate	exposure	
to)	estradiol	leads	to	disturbances	in	the	delicate	balance	of	the	hypothalamic-pituitary-gonadal	
axis	in	both	mice	and	men	(O’Donnell	et	al.,	2001).	The	fact	that	overexposure	to	estradiol	
during	neonatal	development	can	also	produce	similar	defects	in	efferent	duct	function	
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highlights	the	need	for	a	tightly	coordinated	series	of	estradiol-dependent	events	in	this	tissue	
(O’Donnell	et	al.,	2001).	Data	have	shown	increases	of	estradiol	in	males	alter	the	male	
reproductive	tract	as	well	as	spermatogenesis	and	are	consistent	across	vertebrae	classes	
(Hayes	et	al.,	2011).	
	 	
Endocrine	Disrupting	Chemicals	and	Fertility	
	 Recent	patterns	of	infertility	have	been	associated	with	chemicals	that	interfere	with	
the	body’s	endocrine	system,	and	are	commonly	called	endocrine	disruptors.	The	endocrine	
system	is	comprised	of	many	interconnecting	and	interacting	axes	involved	in	almost	every	
process	in	the	body	including:	development,	behavior,	neurologic	activity,	fertility,	and	
maintenance	of	homeostasis	and	it	is	self-regulated	by	the	synthesis,	secretion,	transport,	
binding,	action,	and	clearance	of	natural	hormones	in	the	body.	There	are	many	hormones	
involved	in	these	processes,	for	example:	the	commonly	known	hormone	insulin	is	secreted	
from	the	liver	in	response	to	increases	in	blood	sugar	and	performs	important	physiological	
actions	to	remove	glucose	out	of	the	blood	and	into	storage;	a	less	commonly	known	hormone	
thyroxine	is	secreted	from	the	thyroid	gland	located	in	the	neck	and	is	involved	in	physiological	
actions	such	as	increasing	metabolism	and	is	therefore	permissive	for	growth	and	development.	
Endocrine	disruptors	are	chemicals	(EDCs)	that	may	interfere	with	the	body’s	endocrine	system	
at	any	level	of	these	axes	and	produce	adverse	developmental,	reproductive,	neurological,	
and/or	immune	defects.	EDCs	may	also	mimic	the	actions	associated	with	this	system,	thus	
amplifying	its	effects	on	the	body.	
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	 The	most	widely	known	EDC	to	the	general	public	currently	is	Bisphenol-A	(BPA).	When	
it	was	in	use	for	cheap	production	of	plastic	bottles,	it	would	leech	into	the	bottle’s	fluid	and	
was	found	to	cause	heart	problems	and	was	even	associated	with	the	failure	of	female	egg	
implantation	involved	in	In-Vitro	Fertilization	(Ehrlich	et	al.,	2012).	Common	environmental	
contaminants	can	exhibit	EDC	activity	and	adversely	affect	male	reproductive	tracts	and	
decrease	overall	fertility	as	well	(Toppari	et	al.,	1996).	The	most	prevalently	used	herbicide	
applied	to	crops	by	the	United	States’	agriculture	industry	is	atrazine,	a	chlorotriazine	(2-chloro-
4-ethylamino-6-isopropylamino-s-trizine).	Atrazine	was	introduced	in	the	1950s	as	a	broad	
spectrum	herbicide	to	control	grasses	and	broadleaf	weeds	(Environmental	Protection	Agency,	
2009).	Currently,	atrazine	is	most	commonly	applied	to	sweet	corn,	sorghum,	and	sugarcane,	
and	atrazine	works	by	binding	to	the	QB	protein	of	photosystem	II	in	the	chloroplast,	halting	
photosynthesis	(Stevens	and	Sumner,	1991).	In	agricultural	regions	of	the	United	States,	more	
than	32	pounds	per	square	mile	is	applied	to	crops	on	average.	For	corn	alone,	an	estimated	
63,000,000	pounds	of	atrazine	per	year	is	used	(Swan,	2006).	As	a	result	of	this	usage	it	is	
frequently	detected	in	ground	water,	and	atrazine	seems	to	be	relatively	persistent	compared	
to	other	common-use	herbicides	(J.R.	Vogel	and	J.	I.	Linard,	2011).	Coincidentally,	a	marked	
decline	of	semen	quality	(semen	volume,	sperm	motility,	sperm	count	and	normal	morphology)	
in	normal	men	has	been	reported	over	the	past	few	decades	specifically	in	agricultural	regions	
of	the	United	States	(Swan,	2006).	These	associations	between	current-use	pesticides	and	
reduced	semen	quality	suggest	that	agricultural	chemicals	may	contribute	to	the	recently	
reduced	semen	quality	observed	in	fertile	men	(Swan,	2006).	Results	from	a	study	comparing	
semen	quality	of	men	from	different	regions	of	the	United	States	indicated	that	changes	in	
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semen	quality	were	associated	with	exposure	to	several	common	pesticides	currently	being	
used	(Swan	et	al.,	2003),	including	atrazine.			
	 While	the	reasons	for	these	differences	are	currently	unknown,	both	clinical	and	
laboratory	research	suggest	that	the	adverse	changes	may	be	inter-related	and	have	a	common	
origin	in	fetal	life	or	childhood	(Toppari	et	al.,	1996;	Swan,	2006).	The	growing	number	of	
reports	demonstrating	that	common	environmental	contaminants	and	natural	factors	possess	
estrogenic	activity	presents	the	working	hypothesis	that	the	adverse	trends	in	male	
reproductive	health	may	be,	at	least	in	part,	associated	with	exposure	to	estrogenic	or	other	
hormonally	active	environmental	chemicals	during	fetal	and	childhood	development	in	males	
(Jeng,	2014).	A	controlled	study	measured	metabolites	of	eight	non-persistent,	current-use	
pesticides	in	urine	samples	the	men	had	provided	at	the	time	of	semen	collection.	Pesticide	
metabolite	levels	were	elevated	in	cases	compared	with	controls	for	the	herbicides	alachlor	and	
atrazine	(Swan,	2006).	
	 It	has	been	reported	that	in	females	LH	release	was	suppressed	and	women	who	lived	in	
communities	where	atrazine	is	used	extensively	experienced	increased	menstrual	cycle	
irregularity,	longer	follicular	phases,	and	decreased	levels	of	menstrual	cycle	endocrine	
biomarkers	of	infertile	ovulatory	cycles	(McMullin	et	al.,	2004;	Cragin	et	al.,	2011).	These	results	
were	reported	with	atrazine	levels	below	the	Environmental	Protection	Agency’s	MCL	
(Maximum	Contaminant	Level)	for	atrazine	of	0.003	mg/L	defined	as:	The	level	of	a	
contaminant	in	drinking	water	below	which	there	is	no	known	or	expected	risk	to	health,	which	
is	alarming	(Environmental	Protection	Agency,	2009).	In	a	study	performed	with	male	rats,	they	
experienced	an	increase	in	FSH	synthesis	after	atrazine	exposure,	Leydig	cells	were	of	irregular	
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shape	with	unequal	form,	and	atrazine	provoked	degenerative	changes	in	Sertoli	cell	cytoplasm	
(Kniewald	et	al.,	2000).	This	result	in	males	has	been	hypothesized	to	be	a	possible	mechanism	
by	which	the	male	reproductive	tract	and	overall	fertility	have	been	affected	by	atrazine	in	
agricultural	regions	of	the	United	States	(Babić-Gojmerac	et	al.,	1989).	The	mechanisms	by	
which	atrazine	alters	the	male	reproductive	tract	are	poorly	understood	and	have	not	been	
thoroughly	analyzed,	thus	it	is	important	to	bridge	the	gap	between	infertility	and	atrazine	
exposure	beyond	serum	hormone	analysis	and	epidemiological	data.	
	 The	overall	goal	of	this	study	is	to	investigate	the	hypothesis	that	changes	in	sperm	
production,	maturation,	and	hormone	levels	of	the	male	reproductive	tract	are	consequences	
of	chronic	atrazine	exposure.		
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Chapter	3.	Methodology	
Animals	and	Experimental	Design	
	 Sprague	Dawley	rats	were	chosen	because	they	are	a	common	and	established	model	
for	the	study	of	male	reproductive	tract	function,	including,	but	not	limited	to,	the	testes,	
epididymis	and	seminiferous	tubules	(Iannaccone	and	Jacob,	2009).	Atrazine	was	administered	
daily	via	oral	gavage	to	the	mother	while	they	were	in	gestation	until	rats	were	weaned	off,	as	
well	as	throughout	their	adult	lives	until	seven	months	of	age.	Oral	gavage	was	chosen	because	
it	mimics	the	most	common	mode	of	human	exposure	(drinking	water),	and	it	allows	for	the	
delivery	of	exact	amounts	of	atrazine.		Seven	months	of	age	was	chosen	because	that	is	the	age	
when	rats	are	full	adults,	but	before	we	begin	to	see	any	side	effects	of	aging,	which	appears	
around	twelve	months	of	age.	Three	groups	were	included;	the	first	group	of	ten	rats	was	the	
vehicle	control,	the	second	group	of	nine	rats	was	administered	atrazine	at	a	concentration	of	
0.1	mg/kg,	and	the	third	group	of	nine	rats	was	administered	atrazine	at	a	concentration	of	10	
mg/kg.	Serum	of	each	rat	was	collected	at	time	of	euthanasia	(via	decapitation).	The	testis	and	
epididymis	of	each	subject	were	removed	and	frozen	for	later	analysis,	which	were	the	sources	
of	data	for	this	study.	Animals	were	housed	and	treated	at	Western	Michigan	University	(WMU)	
and	covered	by	a	WMU	animal	use	protocol.	Dr.	Chris	Pearl,	who	has	access	to	these	tissues,	
brought	the	collected	samples	to	GVSU.	
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Daily	Sperm	Production	
Daily	sperm	production	(DSP)	was	determined	using	procedures	similar	to	those	
previously	used	(Clarke	and	Pearl,	2014).	Frozen	testis	samples	were	thawed	and	homogenized	
in	0.9%	NaCl/0.05%	Triton	X-100	at	room	temperature	using	an	OmniTip	tissue	homogenizer.	
The	homogenate	was	brought	to	a	total	volume	of	30	ml,	stored	at	4°C	for	twenty-four	hours,	
and	the	number	of	homogenization-detergent	resistant	spermatids	was	counted	using	a	
hemocytometer.	The	hemocytometer	is	comprised	of	two	sides	containing	25	squares	each.	
Five	squares	on	each	side	were	counted	and	multiplied	by	five	to	account	for	the	entire	grid.	
This	provided	the	number	of	elongated	spermatids	in	the	homogenate.	The	number	of	
elongated	spermatids	counted,	divided	by	the	weight	of	testis	homogenized	provided	
sperm/gram	of	testis.	Sperm/gram	of	testis	provides	a	measure	of	efficiency	for	
spermatogenesis.	Sperm/gram	multiplied	by	total	testis	weight	equals	the	total	number	of	
elongated	spermatids.	Daily	sperm	production	was	calculated	as	the	total	number	of	elongated	
spermatids	per	testis	divided	by	6.1	days,	which	is	the	amount	of	time	for	elongated	spermatids	
to	be	found	in	the	rat	seminiferous	tubule.		
	
Hormone	Analysis	
Blood	and	testicular	concentrations	of	testosterone	and	estradiol	were	determined	by	
competitive	ELISAs	(Enzo	Life	Sciences).	For	testicular	concentrations,	samples	were	thawed	at	
room	temperature	and	minced	into	small	pieces.	Pieces	were	homogenized	in	buffer,	and	
subsequently	centrifuged	to	remove	any	large	portions	of	unsolubilized	tissue.	For	
testosterone,	serum	and	tissue	homogenates	were	mixed	with	a	steroid	displacement	reagent	
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for	15	minutes	and	diluted	in	assay	buffer	to	fall	within	the	range	of	the	standard	curve.	
Testosterone	samples	were	assayed	in	triplicate.	The	plates	were	analyzed	using	an	Epoch	
Microplate	Spectrophotometer	and	Gen5	statistical	software.	For	estradiol,	serum	and	testis	
samples	were	extracted	in	diethyl	ether.	After	freezing	the	aqueous	layer	in	liquid	nitrogen,	the	
ether	was	allowed	to	evaporate	at	room	temperature	overnight	before	the	estradiol	was	
reconstituted	in	assay	buffer.	Reconstituted	samples	were	run	in	triplicate	in	the	ELISA.	LH	and	
FSH	serum	samples	were	analyzed	by	following	the	Virginia	Liquid	Assay	Core.	Testicular	steroid	
values	were	normalized	to	weight	of	tissue	homogenized.	
	
Androgen	Receptor	and	Aromatase	Immunohistochemistry		
	 Tissues	were	paraffin	embedded	and	sectioned	at	a	thickness	of	5	μm	using	a	Leica	RM	
2125	rotary	microtome,	and	placed	on	superfrost	plus	slides.	The	sections	were	deparaffinized	
in	citrisolv	and	rehydrated	in	an	alcohol	series	(100%,	95%,	70%,	water).	Antigen	retrieval	was	
performed	by	submerging	slides	in	a	citric	acid	based	antigen	unmasking	solution	in	Coplin	jars	
and	steam	heated	at	93	degrees	C	for	5	minutes	after	which	they	were	allowed	to	cool	to	room	
temperature.	Aromatase	immunohistochemistry	(IHC)	was	done	without	antigen	retrieval.	After	
a	blocking	step,	tissues	were	incubated	overnight	at	4	degrees	C	with	antibodies	to	Aromatase	
(1:250;	rabbit	anti-rat)	or	Androgen	Receptor	(AR)	(1:250;	MC-20;	rabbit	anti-mouse	AR;	Santa	
Cruz	Biotechnology).	Following	primary	incubation,	sections	were	incubated	with	goat	anti-
rabbit	biotinylated	secondary	antibody	followed	by	an	avidin-biotin	horseradish	peroxidase	
complex	(Vector	Laboratories).	Immunostaining	was	visualized	using	NovaRed	chromagen	
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(Vector	Laboratories).	All	slides	were	counterstained	with	Immunomaster	Hematoxylin	and	
evaluated	by	light	microscopy	at	Grand	Valley	State	University.	
	
Statistical	Analysis	
Twenty-eight	animals	were	used	for	analysis.	Data	were	analyzed	by	two-way	ANOVA	
using	GraphPad	Prism	statistical	software	and	values	reported	as	means	±	SEM.	The	data	were	
tested	for	normality	to	ensure	the	assumptions	of	the	ANOVA	were	satisfied.	If	the	overall	
ANOVA	was	significant,	differences	between	treatments	were	determined	using	Tukey’s	
multiple	comparison	test.	Differences	were	considered	significant	if	p	≤	0.05.	IHC	was	analyzed	
visually	and	staining	intensity	rated	as	strong	positive,	positive,	weak	positive,	or	negative.	
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Chapter	4.	Results	
	
	 To	assess	the	overall	health	of	the	animals,	we	first	looked	at	body	weight.	Body	weights	
of	the	three	atrazine-dose	groups	did	not	differ	significantly.	Rats	raised	in	the	control	group	
had	an	average	body	weight	of	463.6	±	38.2	grams.	Rats	raised	on	the	low	dose	of	atrazine	(0.1	
mg/kg)	had	an	average	body	weight	of	497.2	±	59.9	grams	and	rats	raised	on	the	high	dose	of	
atrazine	(10	mg/kg)	had	an	average	body	weight	of	444.9	±	59.4	grams	(Figure	4).	
	
	
Figure	4.	Body	Weight	
Body	weights	were	similar	between	control,	low	dose,	and	high	dose	treated	rats.		
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	 We	next	looked	at	paired	testis	weight	to	see	if	reproductive	organs	were	affected.	
Atrazine	exposure	did	alter	testis	weight	depending	on	dose	(Figure	5).		Rats	in	the	control	
group	had	an	average	paired	testis	weight	of	4.17	±	0.10	grams	which	did	not	differ	significantly	
from	rats	in	the	high	dose	group	that	had	an	average	testis	weight	of	3.95	±	0.15	grams.	Rats	in	
the	low	dose	group	had	significantly	larger	paired	testis	weights	than	both	the	control	and	the	
high	dose	groups	with	an	average	paired	testis	weight	of	4.58	±	0.11	grams.	
	
Figure	5.	Paired	Testis	Weight	
Paired	testis	weights	were	significantly	higher	in	the	low	dose	group	compared	to	either	control	or	high	
dose	exposure.		There	was	no	significant	difference	in	paired	testis	weights	between	the	control	and	
high	dose	groups.	Columns	labeled	with	different	letters	(a	vs.	b)	indicate	a	significant	difference	at	p	≤	
0.05.	
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	 We	next	looked	at	sperm	per	gram	of	testis.	Sperm	per	gram	of	testis	was	significantly	
lower	in	rats	exposed	to	the	low	dose	of	atrazine	(Figure	6).		Control	rats	had	an	average	sperm	
per	gram	of	94.88	±	1.32	million	which	was	similar	to	rats	in	the	high	dose	with	90.48	±	2.51	
million	sperm	per	gram.	Rats	exposed	to	the	low	dose	of	atrazine	had	a	significantly	lower	
sperm	per	gram	of	testis	with	an	average	of	86.07	±	2.71	million	sperm	per	gram.		
	
Figure	6.	Sperm	Per	Gram	of	Testis		
Rats	exposed	to	the	low	dose	of	atrazine	had	significantly	lower	sperm	per	gram	when	compared	to	
either	the	control	or	high	dose	animals.		There	was	no	significant	difference	between	the	control	and	
high	dose	groups.	Columns	labeled	with	different	letters	(a	vs.	b)	indicate	a	significant	difference	based	
on	p	≤	0.05.	
	
	
	 Daily	sperm	production	is	a	critical	measure	of	fertility	potential	and	both	testis	weight	
and	sperm	per	gram	of	testis	contribute	to	this	value.		Daily	sperm	production	(DSP)	of	the	
three	groups	differed	significantly	between	doses	(Figure	7).	Rats	in	the	control	group	had	a	
DSP	of	64.86	±	1.87	million	sperm,	which	did	not	differ	significantly	from	rats	in	the	low	dose	
group	with	an	average	DSP	of	64.24	±	1.0	million	sperm.	Rats	in	the	high	dose	group	had	a	
significantly	lower	DSP	than	both	the	control	and	low	dose	groups	with	an	average	DSP	of	58.36	
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±	1.78	million	sperm.	Even	though	testis	weight	and	sperm	per	gram	of	testis	were	not	different	
from	controls	in	the	high	dose	group,	it	is	our	interpretation	that	the	interplay	of	small	changes	
in	each	of	these	variables	was	sufficient	to	cause	a	significant	decline	in	DSP.		Interestingly,	DSP	
in	the	low	dose	group	was	not	different	from	the	control	even	though	both	testis	weight	and	
sperm	per	gram	of	testis	were	significantly	different.		However,	these	changes	were	in	opposite	
directions	with	testis	weight	being	larger	and	sperm	per	gram	of	testis	reduced.		When	these	
variables	were	combined	DSP	appears	similar	to	the	control.		Collectively,	these	data	suggest	
that	both	low	and	high	doses	of	atrazine	may	disrupt	testicular	function	and	potential	fertility.			
	
Figure	7.	Daily	Sperm	Production	(Paired	Testis)	
There	was	a	significant	difference	between	the	control	and	high	dose	groups,	as	well	as	between	the	low	
dose	and	high	dose	groups.	There	was	no	significant	difference	between	the	control	and	low	dose	
groups.	Columns	labeled	with	different	letters	(a	vs.	b)	indicate	a	significant	difference	based	on	p	≤	
0.05.	
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	 Since	spermatogenesis	and	testicular	function	depend	on	hormone	signaling,	we	next	
looked	at	serum	hormone	levels	of	gonadotropin	hormones	to	determine	if	the	effect	of	
atrazine	was	altered	via	pituitary	hormone	secretion.	The	concentrations	of	LH	within	the	blood	
were	numerically	higher	in	the	high	dose	group,	but	LH	was	not	significantly	different	between	
the	three	groups	(Figure	8).	The	control	group	had	an	average	of	0.24	ng/ml	±	0.05,	the	lose	
dose	group	had	an	average	of	0.27	ng/ml	±	0.06	and	the	high	dose	group	had	an	average	of	
0.33	ng/ml	±	0.05.		Serum	FSH	levels	were	significantly	different	between	the	three	groups	
(Figure	9).		The	control	group	had	an	average	of	4.47	ng/ml	±	0.40,	the	low	dose	group	had	an	
average	of	4.80	ng/ml	±	0.42	and	the	high	dose	group	had	an	average	of	5.96	ng/ml	±	0.36.		
There	were	no	significant	differences	between	the	control	group	and	the	low	group,	or	the	low	
group	and	the	high	group.	FSH	was	significantly	higher	in	the	high	dose	group	compared	to	the	
control	group.		Thus,	increased	secretion	of	FSH	from	the	pituitary	may	be	contributing	to	the	
changes	in	DSP	induced	by	atrazine.	
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Figure	8.	Serum	LH	
Serum	LH	levels	were	not	significantly	different	between	the	control,	low	dose,	and	high	dose	groups.	
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Figure	9.	Serum	FSH	
Serum	FSH	levels	were	significantly	different	between	the	control	and	the	high	dose	groups.	There	were	
no	significant	differences	between	the	control	and	the	low	dose	group,	or	between	the	low	dose	and	the	
high	dose	groups.	Columns	labeled	with	different	letters	(a	vs.	b)	indicate	a	significant	difference	based	
on	p	≤	0.05.	
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	 Spermatogenesis	is	also	regulated	by	gonadal	steroids	so	we	next	looked	at	
concentrations	of	steroid	hormones	in	both	the	serum	and	testis	tissue.		There	were	no	
significant	differences	in	serum	testosterone	levels	between	the	three	groups	(Figure	10).	The	
control	group	had	an	average	of	3.32	ng/ml	±	0.66,	the	low	dose	group	had	an	average	of	3.51	
ng/ml	±	0.83,	and	the	high	dose	group	had	an	average	of	2.55	ng/ml	±	0.43	.	There	was	a	
significant	difference	in	serum	estradiol	levels	between	the	three	groups	(Figure	11).	The	
control	group	had	an	average	of	3.45	pg/ml	±	0.20,	the	low	dose	group	had	an	average	of	3.72	
pg/ml	±	0.20,	and	the	high	dose	group	had	an	average	of	4.48	pg/ml	±	0.29.	Similar	to	FSH	
levels,	estradiol	was	significantly	higher	in	the	high	dose	group	compared	to	the	control	group	
(Figure	8).			
	 Since	the	testis	produces	testosterone	and	estradiol,	we	also	looked	at	local/tissue	
hormone	concentrations.	There	were	no	significant	differences	in	testosterone	levels	within	the	
testis	(per	gram	of	tissue)	between	the	three	groups.	The	control	group	had	an	average	of	41.74	
ng/g	±	5.92,	the	low	dose	group	had	an	average	of	49.61	ng/g	±	5.33,	and	the	high	dose	group	
had	an	average	of	43.64	ng/g	±	5.98	(Figure	12).		Interestingly,	testis	estradiol	was	reasonably	
different,	but	not	significantly	different,	between	the	three	groups,	even	though	serum	levels	of	
estradiol	were	significantly	different.	The	control	group	had	an	average	of	616.65	pg/g	±	85.2,	
the	low	dose	group	had	an	average	of	684.44	pg/g	±	56.3,	and	the	high	dose	group	had	an	
average	of	718.22	pg/g	±	81.2	(Figure	13).		In	regards	to	steroid	hormones	it	appears	atrazine	
alters	serum	estradiol	and	thus,	in	addition	to	FSH,	could	be	a	mechanism	to	explain	the	altered	
sperm	production	parameters.			
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Figure	10.	Serum	Testosterone	
Serum	testosterone	levels	were	not	significantly	different	between	the	control,	low	dose,	and	high	dose	
groups.	
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Figure	11.	Serum	Estradiol	
There	was	a	significant	difference	in	the	serum	estradiol	levels	between	the	control	and	high	dose	
groups.	There	were	no	significant	differences	between	the	control	and	low	dose	groups,	or	between	the	
low	dose	and	high	dose	groups.	Columns	labeled	with	different	letters	(a	vs.	b)	indicate	a	significant	
difference	based	on	p	≤	0.05.	
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Figure	12.	Testis	Testosterone	
Testis	testosterone	levels	were	not	significantly	different	between	the	control,	low	dose,	and	high	dose	
groups.	 	
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Figure	13.	Testis	Estradiol	
Testis	estradiol	levels	were	not	significantly	different	between	the	control,	low	dose,	and	high	dose	
groups.	
	 	 		
	 39	
	 Since	estradiol	was	increased,	the	testicular	expression	of	the	enzyme	CYP19,	commonly	
known	as	aromatase,	which	converts	testosterone	into	estradiol,	was	next	investigated	via	
immunohistochemistry.	Aromatase	is	localized	in	Leydig	cells	in-between	the	tubules	in	the	
male	testis.	As	shown	in	Figure	14	in	the	interstitial	space	where	the	Leydig	cells	reside,	the	
expression	pattern	of	the	aromatase	has	a	much	higher	intensity	in	the	low	and	high	dose	
groups	(panels	B	and	C,	respectively)	compared	to	the	control	(panel	A),	suggesting	a	much	
higher	expression	of	aromatase	in	the	testes	exposed	to	either	low	or	high	doses	of	atrazine.		
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Figure	14.	Immunohistochemistry	–	CPY19	
CYP19,	commonly	known	as	aromatase,	stained	with	NovaRed.	From	top	to	bottom,	panels	are	arranged	
control	group,	low	dose,	and	high	dose.	IHC	intensity	increased	from	the	control	group	(panel	A)	to	both	
the	low	dose	(panel	B)	and	high	dose	(panel	C).	Arrows	pointing	to	positive	Leydig	cells.	Bar	=	100	μm.	 	
A	
B	
C	
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	 To	further	investigate	a	potential	involvement	of	androgen	signaling,	we	localized	
androgen	receptors	(AR).	AR’s	are	localized	in	both	Leydig	cells	in	the	interstitial	space	as	well	
as	in	Sertoli	cells	within	the	tubules.	The	NovaRed	expression	pattern	for	AR’s	were	distributed	
evenly	among	all	three	groups	suggesting	atrazine	did	not	have	a	significant	effect	on	AR	
expression	within	the	male	testis	(Figure	12).	If	we	noticed	a	difference	in	androgen	receptor	
expression,	we	could	attribute	changes	in	DSP	in	part	to	androgen	signaling.	Since	testosterone	
levels	were	not	shown	to	be	significantly	different	in	the	blood	or	testis,	this	reinforces	our	
observation	that	no	role	was	played	by	testosterone	in	this	process,	and	therefore	we	attribute	
the	observed	changes	to	differences	in	estradiol.		
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Figure	15.	Immunohistochemistry	–	Androgen	Receptor	
Androgen	Receptor	(AR)	was	stained	using	NovaRed.	From	top	to	bottom,	panels	are	arranged	control	
group	(panel	A),	low	dose	(panel	B),	and	high	dose	(panel	C).	There	was	no	observable	difference	in	
expression	patterns	between	any	of	the	groups.	Arrows	pointing	to	positive	Leydig	cells	(LC)	and	Sertoli	
cells	(SC).	Bar	=	100	μm.	
A	
B	
C	
SC	
LC	
LC	
SC	
SC	
LC	
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Chapter	5.	Discussion	and	Conclusion	
	 The	purpose	of	this	study	was	to	investigate	the	effects	of	the	endocrine	disrupting	
chemical	atrazine	on	the	reproductive	health	of	7-month-old	male	Sprague	Dawley	rats.	It	was	
hypothesized	that	atrazine	would	have	a	negative	effect	on	reproductive	function.	This	study	
demonstrated	that	atrazine	adversely	affects	male	Sprague	Dawley	rat	fertility	and	hormone	
levels.	At	7	months	of	age,	rats	raised	on	the	high	dose	of	atrazine	did	not	differ	from	the	
control	group	in	testis	weight	or	sperm/gram,	but	their	daily	sperm	production	(DSP)	was	
significantly	lower	than	both	the	control	and	the	low	dose	groups.	DSP	for	the	rats	raised	in	the	
low	dose	group	did	not	differ	from	the	control,	but	testis	weight	was	significantly	higher	than	
the	control	and	high	dose	groups,	and	the	sperm/gram	was	significantly	lower	than	the	control	
and	high	dose	groups.	Therefore,	these	results	show	that	two	differing	doses	of	atrazine	have	
adverse	effect	on	DSP,	sperm/gram,	and	overall	male	reproductive	function.		
	 Both	FSH	and	estradiol	concentrations	in	the	blood	were	significantly	increased,	as	well	
as	the	concentration	of	the	enzyme	CYP19,	commonly	known	as	aromatase,	responsible	for	
converting	testosterone	into	estradiol.	This	suggests	atrazine	indirectly	increases	estradiol	
concentrations	and	subsequently	decreasing	fertility	via	promoting	the	synthesis	of	aromatase	
among	other	mechanisms.	Analysis	of	LH	and	testosterone	in	the	serum	as	well	as	in	the	testis	
revealed	these	hormone	levels	did	not	change	in	response	to	atrazine.	Also,	
immunohistochemistry	in	the	testis	showed	no	changes	in	androgen	receptor	expression,	the	
primary	receptor	for	testosterone	in	mammalian	males	and	further	confirmed	that	the	
androgen	pathway	did	not	play	a	role	in	the	decreases	in	daily	sperm	production	in	response	to	
atrazine.		
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	 Sertoli	cells	are	among	the	most	essential	components	of	reproductive	physiology	in	
males.	The	cells	support	germ	cell	development	throughout	the	entire	seminiferous	epithelium	
and	help	maintain	the	structural	integrity	of	the	blood-testis	barrier	(França	et	al.,	2016).	This	
blood-testis	barrier	prevents	leukocytes	or	antibodies	from	encountering	developing	germ	cells	
and	triggering	an	autoimmune	response	(Johnson	and	Setchell,	1968).	Sertoli	cell	numbers	
directly	correlate	with	the	efficiency	of	sperm	production	and	are	the	primary	location	of	
androgen	receptors	in	the	testis	(Orth	et	al.,	1988).	Deficiency	in	either	production	or	action	of	
testosterone	will	certainly	cause	infertility	in	males,	and	this	is	true	for	excessively	high	or	low	
levels	(Kliesch,	2010).	Since	testosterone	has	the	most	direct	role	of	maintaining	fertility	within	
mammalian	males,	and	Sertoli	cells	are	the	primary	target	for	testicular	testosterone	as	well	as	
the	maintenance	and	development	of	sperm,	another	factor	must	be	at	play	in	the	testis	due	to	
the	observed	unchanged	levels	of	serum	and	testicular	levels	of	LH,	testosterone,	and	androgen	
receptors	in	all	groups.		
	 Immunohistochemistry	revealed	that	estrogen	receptor	α	(ERα)	was	present	in	Leydig	
cells,	Sertoli	cells,	spermatogonia,	spermatocytes,	round	spermatids	and	elongated	
spermatids/spermatozoa,	while	estrogen	receptor	β	(ERβ)	was	present	in	the	same	cell	types	
except	spermatogonia	and	Sertoli	cells	(Carreau	and	Hess,	2010).	This	study	demonstrates	ERα	
mRNA	expression	in	human	testis	and	describes	its	localization	in	somatic	and	germ	cell	
subtypes.	These	findings	suggest	that	both	ER	isoforms	are	involved	in	the	control	of	testicular	
function	(Cavaco	et	al.,	2009).	Both	ERα	and	ERβ	bind	17β-estradiol	with	high	affinity	and	they	
bind	to	classical	estrogen	response	elements	in	a	similar	if	not	identical	fashion	(Dechering	et	
al.,	2000).	In	the	testes,	spermatogenesis	is	modulated	at	every	level	by	estradiol,	starting	with	
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the	hypothalamic-pituitary-gonadal	axis,	followed	by	the	Leydig,	Sertoli,	and	germ	cells,	and	
finishing	with	the	ductal	epithelium,	epididymis,	and	mature	sperm.	Regulation	of	testicular	
cells	by	estradiol	shows	both	an	inhibitory	and	a	stimulatory	influence,	indicating	an	intricate	
symphony	of	dose-dependent	modulation	(Schulster	et	al.,	2016).	The	fairest	interpretation	of	
the	data	presented	is	that	no	single	factor	is	responsible	for	the	decrease	in	overall	fertility	in	
atrazine	exposed	rats,	but	that	a	complex	interaction	between	both	positive	(increase	in	FSH,	
estradiol	and	aromatase)	and	negative	(decrease	in	testis	weight	and	DSP)	factors	ultimately	
determines	the	level	of	quality	sperm	production.	
	 Body	weights	of	the	low	dose	groups	only	increased	slightly,	yet	the	paired	testis	
weights	of	the	low	dose	group	were	significantly	higher	than	both	the	control	and	the	high	dose	
group.	Interestingly,	the	sperm/g	of	the	low	dose	group	were	shown	to	be	significantly	lower	
than	both	the	control	and	the	high	dose	group.	This	peculiarity	led	the	DSP	for	the	low	dose	
group	to	remain	statistically	insignificant,	though	the	combination	of	increased	testis	weight	
and	decrease	in	sperm/g	hid	this	discrepancy.	Conversely,	a	past	study	found	neonatal	
treatment	of	three	separate	exogenous	estrogens	resulted	in	significant	decreases	in	adult	
testis	weight,	but	similarly	to	the	current	study	sperm/g	also	decreased	significantly	in	response	
to	exposure	to	various	estrogens	and	were	largely	dose	dependent	(Atanassova	et	al.,	1999).	
	 	Control	of	the	endocrine	system	is	a	result	of	proper	hormone	production,	circulation,	
and	clearance	within	the	HPG-axis.	Normally,	estradiol	acts	to	maintain	fertility.	For	example,	it	
has	been	shown	that	FSH	in	combination	with	estradiol	is	necessary	for	the	mRNA	transcription	
of	N-cadherin,	the	protein	responsible	for	cell-to-cell	adhesion.	Thus,	the	dynamic	process	of	
spermatogenesis	involving	Sertoli	cells	separating	and	reforming	tight	junctions	via	N-cadherins	
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is,	at	least	in	part,	regulated	by	estradiol	(MacCalman	et	al.,	1994).	Estradiol	can	also	modulate	
nuclear	transcription	to	trigger	either	proapoptotic	or	antiapoptotic	genes	(Royer	et	al.,	2012).		
	 The	most	likely	issue	related	to	significantly	decreased	sperm	counts	in	the	high	dose	
group	or	low	dose	group	is	the	increase	in	levels	of	estradiol	and	a	disruption	of	normal	
endocrine	function	and	maintenance	within	the	testis	in	utero	and	throughout	development.	
Estradiol	has	exhibited	inhibitory	effects	emphasizing	the	level	of	estradiol	sensitivity	of	
reproductive	mechanisms	within	the	testis.	In	a	previous	study	concerning	healthy	men	and	
possible	male	hormonal	contraception,	administration	of	estradiol	produced	a	dose-dependent	
increase	in	peak	plasma	estradiol	at	one	month	and	prolonged	suppression	of	plasma	LH	and	
FSH	leading	to	significantly	enhanced	suppression	of	sperm	output	(Handelsman	et	al.,	2000).	
Furthermore,	these	effects	of	estradiol	appear	to	manifest	via	central	inhibition	of	
gonadotropin	secretion.	It	is	unreasonable	to	fully	rule	out	additional	direct	effects	of	estradiol	
on	testicular	function.	The	limitations	of	estradiol	illustrated	in	the	present	study	were	that	
while	the	lower	dose	(10	mg)	had	negligible	effects,	only	a	two-fold	higher	dose	(20	mg)	
produced	dose-limiting	adverse	effects.	Hence	estradiol	has	a	narrow	therapeutic	window	
(Handelsman	et	al.,	2000).	The	current	study	observed	similar	effects	of	spermatogenic	
suppression	in	response	to	increases	in	serum	estradiol,	but	conversely	observed	significant	
increases	in	FSH	as	well,	rather	than	decreases.	Thus,	atrazine	may	be	working	under	multiple	
different	mechanisms	throughout	the	endocrine	system.	
	 	Estradiol	has	also	been	shown	to	modulate	the	expression	of	specific	ion	transporters	
and	higher	levels	can	disrupt	Sertoli	cell	metabolic	function,	which	could	partially	explain	the	
disruption	and	decrease	in	sperm	counts	observed	in	this	study	(Martins	et	al.,	2013;Bernardino	
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et	al.,	2016).	In	clinical	settings,	sperm	retrieval	rates	were	seen	to	increase	1.4-fold	either	by	
decreasing	estradiol	directly	and	normalizing	the	ratio	or	testosterone	to	estrogen	with	
aromatase	inhibitors	or	indirectly	blocking	estradiol	centrally	with	clomiphene	citrate,	in	turn,	
increasing	gonadotropin	secretion	(Schulster	et	al.,	2016).	
	 Body	weights	of	rats	in	the	high	group	remained	unchanged	relative	to	the	control.	
Similarly,	the	paired	testis	weights	of	both	the	control	and	high	dose	group	remained	
unchanged,	but	DSP	was	significantly	lower	than	both	the	control	and	the	low	dose	groups.	FSH	
levels	were	not	significantly	different	between	the	control	and	the	low	dose	groups,	or	between	
the	low	dose	and	the	high	dose	groups.	However,	FSH	levels	in	the	high	dose	group	were	
significantly	higher	than	the	control	group.	This	suggests	atrazine	had	a	significant	effect	on	FSH	
synthesis	and	secretion	when	in	high	concentrations.	Following	the	same	pattern,	serum	
estradiol	levels	were	not	significantly	different	between	the	control	and	low	dose	groups,	nor	
between	the	low	dose	and	high	dose	groups.	However,	serum	levels	of	estradiol	in	the	high	
dose	group	were	significantly	higher	than	the	control.	This	suggests	the	elevated	FSH	levels	in	
the	high	dose	group	had	a	significant	effect	on	estradiol	synthesis	or	secretion,	which	resulted	
in	significantly	elevated	estradiol	in	the	serum.	Furthermore,	estradiol	levels	in	the	testis	were	
reasonably	elevated	for	the	high	dose	group	relative	to	the	control,	but	not	enough	to	make	it	
statistically	significant.	Taken	altogether,	these	results	further	emphasize	the	relationship	
between	increasing	estradiol	levels	and	decreased	male	reproductive	function.		
	 It	is	clear	that	exposure	of	the	developing	male	to	exogenous	estrogens	(or	increased	
endogenous	estrogens)	either	in	utero	or	neonatally	can	result	in	a	range	of	abnormalities	of	
reproductive	development	and	function	(Sharpe	et	al.,	1998;Atanassova	et	al.,	1999).	The	latter	
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include	effects	on	the	developing	Sertoli	cells,	which	express	ERβ,	and	suggest	that	
inappropriately	high	estrogen	exposure	during	neonatal	life	can	reduce	final	Sertoli	cell	number	
and	impair	Sertoli	cell	functional	maturation,	one	possible	mechanism	for	how	atrazine	might	
adversely	affect	overall	male	fertility	(Sharpe	et	al.,	1998).	Albatino	et	al.	recently	reported	that	
atrazine	was	able	to	exert	an	estrogen-like	proliferative	activity	in	various	cell	models,	including	
ovarian	and	breast	cancer	cells	and	cancer-associated	fibroblasts,	by	inducing	the	expression	of	
several	estrogen	target	genes	without	binding	or	activating	the	classical	ERα		(Chevalier	et	al.,	
2016).	Specifically,	after	one	hour	of	treatment	with	1	µmol/L	of	atrazine,	increased	levels	of	c-
fos,	CTGF,	cyclin-A,	PR,	BG-1,	and	pS2	were	detected—	all	target	genes	of	estrogen	and	
associated	growth	and	cell-cycle	factors.	These	results	in	ovarian	cancer	cells	suggest	that	
atrazine	triggered	an	increase	through	ERα	and	the	EGFR-MAPK	transduction	pathway	
(Albanito	et	al.,	2015),	another	possible	mechanism	in	which	atrazine	could	disrupt	normal	
male	reproductive	function.	One	other	relevant	atrazine	study	stated	that	an	endocrine	basis	
for	mammary	tumors	in	Sprague	Dawley	rats	is	likely	that	atrazine	leads	to	the	maintenance	of	
elevated	blood	levels	of	17β-estradiol	(E2)	and	prolactin;	the	mechanism	for	tumor	
development	may	include	the	induction	of	aromatase	(CYP19)	and/or	other	P450	oxygenases,	
or	antagonist	action	at	the	estrogen	feedback	receptor	in	the	hypothalamus	(Gammon	et	al.,	
2005).	
	 Aromatase	is	present	largely	in	the	mature	Leydig	cells,	producing	a	significant	amount	
of	the	estradiol	in	the	testis	(Schulster	et	al.,	2016).	The	observed	increase	in	aromatase	
concentration	within	the	testis	suggests	a	means	by	which	estradiol	significantly	increased	
within	the	blood	in	the	high	dose	group	and	reasonably	in	the	low	dose	group.	Aromatase	
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synthesizes	testosterone	into	estradiol,	and	it	is	possible	that	atrazine	could	upregulate	the	
expression	of	aromatase	within	the	testis	itself;	indirectly	increasing	estradiol	levels	and	it’s	
associated	effects	on	male	reproductive	function	and	development.		
	 Non-monotonic	dose-response	(NMDR)	relationships	are	more	frequently	reported	
today	in	experimental	studies	than	they	were	10	years	ago	(Vandenberg	et	al.,	2013).	The	term	
“NMDR”	describes	a	dose-response	relationship	characterized	by	a	curve	whose	slope	changes	
direction	within	the	range	of	tested	doses.	Non-monotonicity	represents	a	challenge	to	
fundamental	concepts	in	toxicology	and	risk	assessment.	Endocrine	disrupting	chemicals	(EDCs)	
are	regularly	associated	with	NMDR	relationships	(Lagarde	et	al.,	2015).	Of	the	231	publications	
related	to	EDCs	assessed	in	a	qualitative	literature	review,	51	experimental	studies	described	
one	or	more	NMDR	profile	concerning	EDCs	and/or	natural	hormones,	or	22%.	From	these	51	
studies,	170	dose-effect	relationships	were	claimed	by	authors	as	NMDR,	and	the	most	often-
cited	substances	were	BPA	and	17β-	estradiol	(Lagarde	et	al.,	2015).	Of	the	same	51	studies,	17	
involved	male	reproductive	organs	including:	testes,	epididymis,	seminal	vesicle,	preputial	
glands,	and	prostate.	All	of	which	involved	BPA	or	17β-	estradiol	(Lagarde	et	al.,	2015).		
	 As	clearly	stated	by	Vandenberg	et	al.,	“if	a	non-monotonic	relationship	occurs	between	
the	doses	tested	in	traditional	toxicology	studies	and	the	calculated	“safe”	or	reference	dose,	
this	would	still	have	serious	implications	for	risk	assessment,”	(Vandenberg	et	al.,	2013).	
Further	studies	should	aim	to	explore	ad	identify	the	mechanisms	through	which	atrazine	works	
within	the	male	testis.	Specifically,	whether	or	not	atrazine	acts	as	a	modulator	of	estrogenic	
activity	and	synthesis,	an	upregulator	of	aromatase,	or	perhaps	further	upstream	in	the	
pituitary	from	where	FSH	is	secreted.	An	area	of	interest	beyond	the	scope	of	this	study	could	
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be	the	analysis	of	why	aromatase	would	increase	in	the	presence	of	atrazine	and	what	levels	of	
estradiol	are	destructive	in	the	developing	and	adult	male	reproductive	tract.		
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